vs
ICU MEDICAL INC（ICUI）与Mid-America Apartment Communities（MAA）财务数据对比。点击上方公司名可切换其他公司
Mid-America Apartment Communities的季度营收约是ICU MEDICAL INC的1.0倍（$555.6M vs $540.7M），Mid-America Apartment Communities净利率更高（10.4% vs -2.9%，领先13.3%），Mid-America Apartment Communities同比增速更快（1.0% vs -14.1%），Mid-America Apartment Communities自由现金流更多（$158.6M vs $36.0M），过去两年Mid-America Apartment Communities的营收复合增速更高（1.1% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Mid-America Apartment Communities（股票代码：MAA）是一家公开上市的房地产投资信托基金，总部位于美国田纳西州孟菲斯市，核心业务为投资美国东南部及西南部地区的公寓物业，深耕美国高增长区域住宅不动产赛道，为股东创造稳定的长期投资回报。
ICUI vs MAA — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $555.6M |
| 净利润 | $-15.7M | $57.6M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 10.4% |
| 净利率 | -2.9% | 10.4% |
| 营收同比 | -14.1% | 1.0% |
| 净利润同比 | 34.0% | -65.5% |
| 每股收益（稀释后） | $-0.63 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $555.6M | ||
| Q3 25 | $537.0M | $554.4M | ||
| Q2 25 | $548.9M | $549.9M | ||
| Q1 25 | $604.7M | $549.3M | ||
| Q4 24 | $629.8M | $549.8M | ||
| Q3 24 | $589.1M | $551.1M | ||
| Q2 24 | $596.5M | $546.4M | ||
| Q1 24 | $566.7M | $543.6M |
| Q4 25 | $-15.7M | $57.6M | ||
| Q3 25 | $-3.4M | $99.5M | ||
| Q2 25 | $35.3M | $108.1M | ||
| Q1 25 | $-15.5M | $181.7M | ||
| Q4 24 | $-23.8M | $166.6M | ||
| Q3 24 | $-33.0M | $115.2M | ||
| Q2 24 | $-21.4M | $102.0M | ||
| Q1 24 | $-39.5M | $143.7M |
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
| Q4 25 | 1.0% | 10.4% | ||
| Q3 25 | 2.6% | 18.7% | ||
| Q2 25 | 1.9% | 20.2% | ||
| Q1 25 | 2.1% | 34.0% | ||
| Q4 24 | 6.0% | 31.3% | ||
| Q3 24 | 1.4% | 21.5% | ||
| Q2 24 | 1.3% | 19.3% | ||
| Q1 24 | -1.9% | 27.4% |
| Q4 25 | -2.9% | 10.4% | ||
| Q3 25 | -0.6% | 18.0% | ||
| Q2 25 | 6.4% | 19.7% | ||
| Q1 25 | -2.6% | 33.1% | ||
| Q4 24 | -3.8% | 30.3% | ||
| Q3 24 | -5.6% | 20.9% | ||
| Q2 24 | -3.6% | 18.7% | ||
| Q1 24 | -7.0% | 26.4% |
| Q4 25 | $-0.63 | $0.48 | ||
| Q3 25 | $-0.14 | $0.84 | ||
| Q2 25 | $1.43 | $0.92 | ||
| Q1 25 | $-0.63 | $1.54 | ||
| Q4 24 | $-0.97 | $1.43 | ||
| Q3 24 | $-1.35 | $0.98 | ||
| Q2 24 | $-0.88 | $0.86 | ||
| Q1 24 | $-1.63 | $1.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $60.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $5.7B |
| 总资产 | $4.1B | $12.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $60.3M | ||
| Q3 25 | — | $32.2M | ||
| Q2 25 | — | $54.5M | ||
| Q1 25 | — | $55.8M | ||
| Q4 24 | $308.6M | $43.0M | ||
| Q3 24 | $312.5M | $50.2M | ||
| Q2 24 | $302.6M | $62.8M | ||
| Q1 24 | $251.4M | $54.6M |
| Q4 25 | $2.1B | $5.7B | ||
| Q3 25 | $2.1B | $5.8B | ||
| Q2 25 | $2.1B | $5.9B | ||
| Q1 25 | $2.0B | $5.9B | ||
| Q4 24 | $2.0B | $5.9B | ||
| Q3 24 | $2.0B | $5.9B | ||
| Q2 24 | $2.0B | $6.0B | ||
| Q1 24 | $2.1B | $6.1B |
| Q4 25 | $4.1B | $12.0B | ||
| Q3 25 | $4.1B | $11.9B | ||
| Q2 25 | $4.1B | $11.8B | ||
| Q1 25 | $4.2B | $11.8B | ||
| Q4 24 | $4.2B | $11.8B | ||
| Q3 24 | $4.3B | $11.8B | ||
| Q2 24 | $4.3B | $11.6B | ||
| Q1 24 | $4.3B | $11.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $261.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $158.6M |
| 自由现金流率自由现金流/营收 | 6.6% | 28.5% |
| 资本支出强度资本支出/营收 | 4.6% | 18.6% |
| 现金转化率经营现金流/净利润 | — | 4.55× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $717.9M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $261.7M | ||
| Q3 25 | $56.7M | $266.4M | ||
| Q2 25 | $11.2M | $353.4M | ||
| Q1 25 | $51.3M | $196.6M | ||
| Q4 24 | $40.2M | $239.1M | ||
| Q3 24 | $36.1M | $309.5M | ||
| Q2 24 | $82.0M | $349.4M | ||
| Q1 24 | $45.8M | $200.3M |
| Q4 25 | $36.0M | $158.6M | ||
| Q3 25 | $27.6M | $170.8M | ||
| Q2 25 | $-8.5M | $264.5M | ||
| Q1 25 | $36.7M | $124.0M | ||
| Q4 24 | $16.1M | $152.6M | ||
| Q3 24 | $16.2M | $215.5M | ||
| Q2 24 | $62.5M | $259.7M | ||
| Q1 24 | $29.9M | $148.2M |
| Q4 25 | 6.6% | 28.5% | ||
| Q3 25 | 5.1% | 30.8% | ||
| Q2 25 | -1.5% | 48.1% | ||
| Q1 25 | 6.1% | 22.6% | ||
| Q4 24 | 2.6% | 27.8% | ||
| Q3 24 | 2.7% | 39.1% | ||
| Q2 24 | 10.5% | 47.5% | ||
| Q1 24 | 5.3% | 27.3% |
| Q4 25 | 4.6% | 18.6% | ||
| Q3 25 | 5.4% | 17.2% | ||
| Q2 25 | 3.6% | 16.2% | ||
| Q1 25 | 2.4% | 13.2% | ||
| Q4 24 | 3.8% | 15.7% | ||
| Q3 24 | 3.4% | 17.1% | ||
| Q2 24 | 3.3% | 16.4% | ||
| Q1 24 | 2.8% | 9.6% |
| Q4 25 | — | 4.55× | ||
| Q3 25 | — | 2.68× | ||
| Q2 25 | 0.32× | 3.27× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 2.69× | ||
| Q2 24 | — | 3.43× | ||
| Q1 24 | — | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
MAA
| Same Store | $515.5M | 93% |
| Non Same Store And Other | $36.8M | 7% |
